This work is licensed under a Creative Commons Attribution 4.0 International License.
LT-2
General Information
DRACP ID DRACP06077
Peptide Name LT-2
Sequence FHIVELLALDQSLSLSVDGGNPKIIT
Sequence Length 26
UniProt ID Not available
PubChem CID Not available
Origin Synthetic (Derived from SLIT2 protein)
Type Synthetic peptide
Classification
Active ACP
Activity Information
Hemolytic Activity Not available
Normal (non-cancerous) Cytotoxicity Not available
Target Not available
Affinity Not available
Mechanism Not available
Nature Anticancer
Structure Information
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Free
Other Modification None
Chiral L
Physicochemical Information
Formula C126H207N31O39
Absent amino acids CMRWY
Common amino acids L
Mass 322634
Pl 4.37
Basic residues 2
Acidic residues 3
Hydrophobic residues 12
Net charge -1
Boman Index -530
Hydrophobicity 59.23
Aliphatic Index 146.15
Half Life
Mammalian: 4.4 hour
Yeast: >20 hour
E.coli: >10 hour
Extinction Coefficient cystines 0
Absorbance 280nm 0
Polar residues 7
Amino acid distribution
Literature Information
Literature 1
Pubmed ID Not available
Title Not available
Doi Not available
Year Not available
Patent
Patent ID CN111032679A
Patent Title Peptides for Cancer Treatment
Other Iinformation Not available
Other Published ID Not available
This work is licensed under a Creative Commons Attribution 4.0 International License.